<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39380801</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>10</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1188-4169</ISSN><JournalIssue CitedMedium="Print"><Volume>50</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Canada communicable disease report = Releve des maladies transmissibles au Canada</Title><ISOAbbreviation>Can Commun Dis Rep</ISOAbbreviation></Journal><ArticleTitle>Mathematical modelling for pandemic preparedness in Canada: Learning from COVID-19.</ArticleTitle><Pagination><StartPage>345</StartPage><EndPage>356</EndPage><MedlinePgn>345-356</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.14745/ccdr.v50i10a03</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">The COVID-19 pandemic underlined the need for pandemic planning but also brought into focus the use of mathematical modelling to support public health decisions. The types of models needed (compartment, agent-based, importation) are described. Best practices regarding biological realism (including the need for multidisciplinary expert advisors to modellers), model complexity, consideration of uncertainty and communications to decision-makers and the public are outlined.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A narrative review was developed from the experiences of COVID-19 by members of the Public Health Agency of Canada External Modelling Network for Infectious Diseases (PHAC EMN-ID), a national community of practice on mathematical modelling of infectious diseases for public health.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Modelling can best support pandemic preparedness in two ways: 1) by modelling to support decisions on resource needs for likely future pandemics by estimating numbers of infections, hospitalized cases and cases needing intensive care, associated with epidemics of "hypothetical-yet-plausible" pandemic pathogens in Canada; and 2) by having ready-to-go modelling methods that can be readily adapted to the features of an emerging pandemic pathogen and used for long-range forecasting of the epidemic in Canada, as well as to explore scenarios to support public health decisions on the use of interventions.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">There is a need for modelling expertise within public health organizations in Canada, linked to modellers in academia in a community of practice, within which relationships built outside of times of crisis can be applied to enhance modelling during public health emergencies. Key challenges to modelling for pandemic preparedness include the availability of linked public health, hospital and genomic data in Canada.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ogden</LastName><ForeName>Nicholas H</ForeName><Initials>NH</Initials><AffiliationInfo><Affiliation>Public Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Acheson</LastName><ForeName>Emily S</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>Public Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Public Health Ontario, Toronto, ON.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dalla Lana School of Public Health, University of Toronto, Toronto, ON.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Champredon</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Public Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colijn</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Mathematics, Simon Fraser University, Burnaby, BC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diener</LastName><ForeName>Alan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Health Policy Branch, Health Canada, Ottawa, ON.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dushoff</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biology and Michael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, ON.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Earn</LastName><ForeName>David Jd</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Department of Mathematics and Statistics and Michael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, ON.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gabriele-Rivet</LastName><ForeName>Vanessa</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Public Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gangbè</LastName><ForeName>Marcellin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Public Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guillouzic</LastName><ForeName>Steve</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre for Operational Research and Analysis, Defence Research and Development Canada, Department of National Defence, Ottawa, ON.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hennessy</LastName><ForeName>Deirdre</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Health Analysis Division, Analytical Studies and Modelling Branch, Statistics Canada, Ottawa, ON.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hongoh</LastName><ForeName>Valerie</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Public Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hurford</LastName><ForeName>Amy</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biology and Department of Mathematics and Statistics, Memorial University of Newfoundland, St. John's, NL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kanary</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Public Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Public Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Victoria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Public Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Otto</LastName><ForeName>Sarah P</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>Department of Zoology and Biodiversity Research Centre, University of British Columbia, Vancouver, BC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papst</LastName><ForeName>Irena</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Public Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rees</LastName><ForeName>Erin E</ForeName><Initials>EE</Initials><AffiliationInfo><Affiliation>Public Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tuite</LastName><ForeName>Ashleigh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Dalla Lana School of Public Health, University of Toronto, Toronto, ON.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Immunization Programs, Public Health Agency of Canada, Ottawa, ON.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>MacLeod</LastName><ForeName>Matthew R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Centre for Operational Research and Analysis, Defence Research and Development Canada, Department of National Defence, Ottawa, ON.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murall</LastName><ForeName>Carmen Lia</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Public Health Genomics Division, National Microbiology Laboratory, Public Health Agency of Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waddell</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Public Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wasfi</LastName><ForeName>Rania</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Public Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wolfson</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Faculty of Law-Common Law, University of Ottawa, Ottawa, ON.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>Can Commun Dis Rep</MedlineTA><NlmUniqueID>9303729</NlmUniqueID><ISSNLinking>1188-4169</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">infectious diseases</Keyword><Keyword MajorTopicYN="N">mathematical modelling</Keyword><Keyword MajorTopicYN="N">pandemic preparedness</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>4</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39380801</ArticleId><ArticleId IdType="pmc">PMC11460797</ArticleId><ArticleId IdType="doi">10.14745/ccdr.v50i10a03</ArticleId><ArticleId IdType="pii">501003</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wu JT, Cowling BJ. The use of mathematical models to inform influenza pandemic preparedness and response. Exp Biol Med (Maywood) 2011;236(8):955–61. 10.1258/ebm.2010.010271</Citation><ArticleIdList><ArticleId IdType="doi">10.1258/ebm.2010.010271</ArticleId><ArticleId IdType="pmc">PMC3178755</ArticleId><ArticleId IdType="pubmed">21727183</ArticleId></ArticleIdList></Reference><Reference><Citation>Viboud C, Sun K, Gaffey R, Ajelli M, Fumanelli L, Merler S, Zhang Q, Chowell G, Simonsen L, Vespignani A; RAPIDD Ebola Forecasting Challenge group . The RAPIDD ebola forecasting challenge: synthesis and lessons learnt. Epidemics 2018;22:13–21. 10.1016/j.epidem.2017.08.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.epidem.2017.08.002</ArticleId><ArticleId IdType="pmc">PMC5927600</ArticleId><ArticleId IdType="pubmed">28958414</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Non-pharmaceutical public health measures for mitigating the risk and impact of epidemic and pandemic influenza. Geneva, CH: WHO; 2019. https://www.who.int/publications/i/item/non-pharmaceutical-public-health-measuresfor-mitigating-the-risk-and-impact-of-epidemic-and-pandemic-influenza</Citation></Reference><Reference><Citation>Fisman D; Pandemic Influenza Outbreak Research Modelling Team (Pan-InfORM) . Modelling an influenza pandemic: A guide for the perplexed. CMAJ 2009;181(3-4):171–3. 10.1503/cmaj.090885</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.090885</ArticleId><ArticleId IdType="pmc">PMC2717691</ArticleId><ArticleId IdType="pubmed">19620267</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuite AR, Fisman DN, Kwong JC, Greer AL. Optimal pandemic influenza vaccine allocation strategies for the Canadian population. PLoS One 2010;5(5):e10520. 10.1371/journal.pone.0010520</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0010520</ArticleId><ArticleId IdType="pmc">PMC2865540</ArticleId><ArticleId IdType="pubmed">20463898</ArticleId></ArticleIdList></Reference><Reference><Citation>Moghadas SM, Pizzi NJ, Wu J, Tamblyn SE, Fisman DN. Canada in the face of the 2009 H1N1 pandemic. Influenza Other Respir Viruses 2011;5(2):83–8. 10.1111/j.1750-2659.2010.00184.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1750-2659.2010.00184.x</ArticleId><ArticleId IdType="pmc">PMC4942003</ArticleId><ArticleId IdType="pubmed">21306571</ArticleId></ArticleIdList></Reference><Reference><Citation>Greer AL, Schanzer D. Using a Dynamic Model to Consider Optimal Antiviral Stockpile Size in the Face of Pandemic Influenza Uncertainty. PLoS One 2013;8(6):e67253. 10.1371/journal.pone.0067253</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0067253</ArticleId><ArticleId IdType="pmc">PMC3689716</ArticleId><ArticleId IdType="pubmed">23805303</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Prioritizing diseases for research and development in emergency contexts. Geneva, CH: WHO; 2024. https://www.who.int/activities/prioritizing-diseases-for-research-and-development-in-emergency-contexts</Citation></Reference><Reference><Citation>Ogden NH, Bouchard C, Brankston G, Brown E, Corrin T, Dibernardo A. Infectious diseases. Health of Canadians in a Changing Climate: Advancing Our Knowledge for Action. Ottawa, ON: Health Canada; 2022. [Accessed 2024 Sept 10]. https://changingclimate.ca/health-in-a-changing-climate/</Citation></Reference><Reference><Citation>Guillouzic S, MacLeod MR, Waller D, Bourdon S. How Flexible OR&amp;A Teams Provided Decision Advantage through Pandemic Uncertainty. Proceedings of the 15th NATO Operational Research &amp; Analysis Conference. 2021. https://cradpdf.drdc-rddc.gc.ca/PDFS/unc472/p815024_A1b.pdf#:~:text=How%20Flexible%20OR&amp;A%20Teams%20Provided</Citation></Reference><Reference><Citation>Becker AD, Grantz KH, Hegde ST, Bérubé S, Cummings DA, Wesolowski A. Development and dissemination of infectious disease dynamic transmission models during the COVID-19 pandemic: what can we learn from other pathogens and how can we move forward? Lancet Digit Health 2021;3(1):e41–50. 10.1016/S2589-7500(20)30268-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(20)30268-5</ArticleId><ArticleId IdType="pmc">PMC7836381</ArticleId><ArticleId IdType="pubmed">33735068</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson J, McClure R, Scott N, Hellard M, Abeysuriya R, Vidanaarachchi R, Thwaites J, Lazarus JV, Lavis J, Michie S, Bullen C, Prokopenko M, Chang SL, Cliff OM, Zachreson C, Blakely A, Wilson T, Ouakrim DA, Sundararajan V. A framework for considering the utility of models when facing tough decisions in public health: a guideline for policy-makers. Health Res Policy Syst 2022;20(1):107. 10.1186/s12961-022-00902-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12961-022-00902-6</ArticleId><ArticleId IdType="pmc">PMC9547676</ArticleId><ArticleId IdType="pubmed">36209122</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks RJ, Tobias AM. Choosing the best model: level of detail complexity and model performance. Math Comput Model 1996;24(4):1–14. 10.1016/0895-7177(96)00103-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0895-7177(96)00103-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Basu S, Andrews J. Complexity in mathematical models of public health policies: a guide for consumers of models. PLoS Med 2013;10(10):e1001540. 10.1371/journal.pmed.1001540</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1001540</ArticleId><ArticleId IdType="pmc">PMC3812083</ArticleId><ArticleId IdType="pubmed">24204214</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, Dushoff J, Bolker BM. Fitting mechanistic epidemic models to data: A comparison of simple Markov chain Monte Carlo approaches. Stat Methods Med Res 2018;27(7):1956–67. 10.1177/0962280217747054</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0962280217747054</ArticleId><ArticleId IdType="pmc">PMC6027774</ArticleId><ArticleId IdType="pubmed">29846150</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernon I, Owen J, Aylett-Bullock J, Cuesta-Lazaro C, Frawley J, Quera-Bofarull A, Sedgewick A, Shi D, Truong H, Turner M, Walker J, Caulfield T, Fong K, Krauss F. Bayesian emulation and history matching of JUNE. Philos Trans A Math Phys Eng Sci 2022;380(2233):20220039. 10.1098/rsta.2022.0039</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsta.2022.0039</ArticleId><ArticleId IdType="pmc">PMC9376712</ArticleId><ArticleId IdType="pubmed">35965471</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallo L, Frasca M, Latora V, Russo G. Lack of practical identifiability may hamper reliable predictions in COVID-19 epidemic models. Sci Adv 2022;8(3):eabg5234. 10.1126/sciadv.abg5234</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abg5234</ArticleId><ArticleId IdType="pmc">PMC8769547</ArticleId><ArticleId IdType="pubmed">35044820</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharya P, Chen J, Hoops S, Machi D, Lewis B, Venkatramanan S, Wilson ML, Klahn B, Adiga A, Hurt B, Outten J, Adiga A, Warren A, Baek YY, Porebski P, Marathe A, Xie D, Swarup S, Vullikanti A, Mortveit H, Eubank S, Barrett CL, Marathe M. Data-driven scalable pipeline using national agent-based models for real-time pandemic response and decision support. Int J High Perform Comput Appl 2023;37(1):4–27. 10.1177/10943420221127034</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10943420221127034</ArticleId><ArticleId IdType="pmc">PMC9596688</ArticleId><ArticleId IdType="pubmed">38603425</ArticleId></ArticleIdList></Reference><Reference><Citation>Public Health Agency of Canada. COVID-19 in Canada: Using data and modelling to inform public health action. Ottawa, ON: PHAC; 2020. https://www.canada.ca/content/dam/phac-aspc/documents/services/diseases/2019-novel-coronavirus-infection/using-data-modelling-inform-eng.pdf</Citation></Reference><Reference><Citation>Kleijnen JP. Verification and validation of simulation models. Eur J Oper Res 1995;82(1):145–62. 10.1016/0377-2217(94)00016-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0377-2217(94)00016-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Balci O. Verification, Validation, and Testing. In Handbook of Simulation. Wiley Online Library 1998. 10.1002/9780470172445.ch1010.1002/9780470172445.ch10</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/9780470172445.ch10</ArticleId><ArticleId IdType="doi">10.1002/9780470172445.ch10</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollett S, Johansson MA, Reich NG, Brett-Major D, Del Valle SY, Venkatramanan S, Lowe R, Porco T, Berry IM, Deshpande A, Kraemer MU, Blazes DL, Pan-Ngum W, Vespigiani A, Mate SE, Silal SP, Kandula S, Sippy R, Quandelacy TM, Morgan JJ, Ball J, Morton LC, Althouse BM, Pavlin J, van Panhuis W, Riley S, Biggerstaff M, Viboud C, Brady O, Rivers C. Recommended reporting items for epidemic forecasting and prediction research: the EPIFORGE 2020 guidelines. PLoS Med 2021;18(10):e1003793. 10.1371/journal.pmed.1003793</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003793</ArticleId><ArticleId IdType="pmc">PMC8525759</ArticleId><ArticleId IdType="pubmed">34665805</ArticleId></ArticleIdList></Reference><Reference><Citation>Milwid RM, Gabriele-Rivet V, Ogden NH, Turgeon P, Fazil A, London D, de Montigny S, Rees EE. A methodology for estimating SARS-CoV-2 importation risk by air travel into Canada between July and November 2021. BMC Public Health 2024;24(1):1088. 10.1186/s12889-024-18563-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-024-18563-1</ArticleId><ArticleId IdType="pmc">PMC11027292</ArticleId><ArticleId IdType="pubmed">38641571</ArticleId></ArticleIdList></Reference><Reference><Citation>Tardy O, Vincenot CE, Bouchard C, Ogden NH, Leighton PA. Context-dependent host dispersal and habitat fragmentation determine heterogeneity in infected tick burdens: an agent-based modelling study. R Soc Open Sci 2022;9(3):220245. 10.1098/rsos.220245</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsos.220245</ArticleId><ArticleId IdType="pmc">PMC8965412</ArticleId><ArticleId IdType="pubmed">35360357</ArticleId></ArticleIdList></Reference><Reference><Citation>Prem K, Cook AR, Jit M. Projecting social contact matrices in 152 countries using contact surveys and demographic data. PLOS Comput Biol 2017;13(9):e1005697. 10.1371/journal.pcbi.1005697</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1005697</ArticleId><ArticleId IdType="pmc">PMC5609774</ArticleId><ArticleId IdType="pubmed">28898249</ArticleId></ArticleIdList></Reference><Reference><Citation>Mistry D, Litvinova M, Pastore Y Piontti A, Chinazzi M, Fumanelli L, Gomes MF, Haque SA, Liu QH, Mu K, Xiong X, Halloran ME, Longini IM Jr, Merler S, Ajelli M, Vespignani A. Inferring high-resolution human mixing patterns for disease modeling. Nat Commun 2021;12(1):323. 10.1038/s41467-020-20544-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-20544-y</ArticleId><ArticleId IdType="pmc">PMC7803761</ArticleId><ArticleId IdType="pubmed">33436609</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Hoogen J, Okazawa S. A Stochastic Model of COVID-19 Infections During a Large-Scale Canadian Army Exercise. The 15th NATO Operations Research &amp; Analysis (OR&amp;A) Conference Proceedings: Emerging and Disruptive Technology NATO STO Review. Ottawa, ON: National Defence; 2022. https://cradpdf.drdc-rddc.gc.ca/PDFS/unc399/p814956_A1b.pdf</Citation></Reference><Reference><Citation>Okazawa S, van den Hoogen J, Guillouzic S. PyCoMod (Python Compartment Modelling) Programming Reference. Defence Research and Development Canada DRDC-RDDC-2023-D111. Ottawa, ON: Government of Canada; 2023. https://pubs.drdc-rddc.gc.ca/BASIS/pcandid/www/engpub/DDW?W%3DSYSNUM=817298&amp;r=0</Citation></Reference><Reference><Citation>Day T, Kennedy DA, Read AF, Gandon S. Pathogen evolution during vaccination campaigns. PLoS Biol 2022;20(9):e3001804. 10.1371/journal.pbio.3001804</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3001804</ArticleId><ArticleId IdType="pmc">PMC9553060</ArticleId><ArticleId IdType="pubmed">36149891</ArticleId></ArticleIdList></Reference><Reference><Citation>Otto SP, Day T, Arino J, Colijn C, Dushoff J, Li M, Mechai S, Van Domselaar G, Wu J, Earn DJ, Ogden NH. The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic. Curr Biol 2021;31(14):R918–29. 10.1016/j.cub.2021.06.049</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2021.06.049</ArticleId><ArticleId IdType="pmc">PMC8220957</ArticleId><ArticleId IdType="pubmed">34314723</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng V, Fazil A, Waddell LA, Bancej C, Turgeon P, Otten A, Atchessi N, Ogden NH. Projected effects of nonpharmaceutical public health interventions to prevent resurgence of SARS-CoV-2 transmission in Canada. CMAJ 2020;192(37):E1053–64. 10.1503/cmaj.200990</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.200990</ArticleId><ArticleId IdType="pmc">PMC7513947</ArticleId><ArticleId IdType="pubmed">32778573</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabriele-Rivet V, Spence KL, Ogden NH, Fazil A, Turgeon P, Otten A, Waddell LA, Ng V. Modelling the impact of age-stratified public health measures on SARS-CoV-2 transmission in Canada. R Soc Open Sci 2021;8(11):210834. 10.1098/rsos.210834</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsos.210834</ArticleId><ArticleId IdType="pmc">PMC8562391</ArticleId><ArticleId IdType="pubmed">34737875</ArticleId></ArticleIdList></Reference><Reference><Citation>Tardy O, Bouchard C, Chamberland E, Fortin A, Lamirande P, Ogden NH, Leighton PA. Mechanistic movement models reveal ecological drivers of tick-borne pathogen spread. J R Soc Interface 2021;18(181):20210134. 10.1098/rsif.2021.0134</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsif.2021.0134</ArticleId><ArticleId IdType="pmc">PMC8355688</ArticleId><ArticleId IdType="pubmed">34376091</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammadi Z, Cojocaru M, Arino J, Hurford A. Importation models for travel-related SARS-CoV-2 cases reported in Newfoundland and Labrador during the COVID-19 pandemic. medRxiv 2023; 23291136. 10.1101/2023.06.08.23291136</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.06.08.23291136</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurford A, Martignoni MM, Loredo-Osti JC, Anokye F, Arino J, Husain BS, Gaas B, Watmough J. Pandemic modelling for regions implementing an elimination strategy. J Theor Biol 2023;561:111378. 10.1016/j.jtbi.2022.111378</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtbi.2022.111378</ArticleId><ArticleId IdType="pmc">PMC9794400</ArticleId><ArticleId IdType="pubmed">36584747</ArticleId></ArticleIdList></Reference><Reference><Citation>du Plessis L, McCrone JT, Zarebski AE, Hill V, Ruis C, Gutierrez B, Raghwani J, Ashworth J, Colquhoun R, Connor TR, Faria NR, Jackson B, Loman NJ, O’Toole Á, Nicholls SM, Parag KV, Scher E, Vasylyeva TI, Volz EM, Watts A, Bogoch II, Khan K, Aanensen DM, Kraemer MU, Rambaut A, Pybus OG; COVID-19 Genomics UK (COG-UK) Consortium . Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK. Science 2021;371(6530):708–12. 10.1126/science.abf2946</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abf2946</ArticleId><ArticleId IdType="pmc">PMC7877493</ArticleId><ArticleId IdType="pubmed">33419936</ArticleId></ArticleIdList></Reference><Reference><Citation>Murall CL, Fournier E, Galvez JH, N’Guessan A, Reiling SJ, Quirion PO, Naderi S, Roy AM, Chen SH, Stretenowich P, Bourgey M, Bujold D, Gregoire R, Lepage P, St-Cyr J, Willet P, Dion R, Charest H, Lathrop M, Roger M, Bourque G, Ragoussis J, Shapiro BJ, Moreira S. A small number of early introductions seeded widespread transmission of SARS-CoV-2 in Québec, Canada. Genome Med 2021;13(1):169. 10.1186/s13073-021-00986-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13073-021-00986-9</ArticleId><ArticleId IdType="pmc">PMC8550813</ArticleId><ArticleId IdType="pubmed">34706766</ArticleId></ArticleIdList></Reference><Reference><Citation>McLaughlin A, Montoya V, Miller RL, Mordecai GJ, Worobey M, Poon AF, Joy JB; Canadian COVID-19 Genomics Network (CanCOGen) Consortium . Genomic epidemiology of the first two waves of SARS-CoV-2 in Canada. eLife 2022;11:e73896. 10.7554/eLife.73896</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.73896</ArticleId><ArticleId IdType="pmc">PMC9345601</ArticleId><ArticleId IdType="pubmed">35916373</ArticleId></ArticleIdList></Reference><Reference><Citation>Nextstrain: Real-time tracking of pathogen evolution. [Accessed 2024 Aug 27]. https://nextstrain.org</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6247931</ArticleId><ArticleId IdType="pubmed">29790939</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SW, Sun K, Champredon D, Li M, Bolker BM, Earn DJ, Weitz JS, Grenfell BT, Dushoff J. Forward-looking serial intervals correctly link epidemic growth to reproduction numbers. Proc Natl Acad Sci USA 2021;118(2):e2011548118. 10.1073/pnas.2011548118</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2011548118</ArticleId><ArticleId IdType="pmc">PMC7812760</ArticleId><ArticleId IdType="pubmed">33361331</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai X, Champredon D, Fazil A, Mangat CS, Peterson SW, Mejia EM, Lu X, Chekouo T. Statistical framework to support the epidemiological interpretation of SARS-CoV-2 concentration in municipal wastewater. Sci Rep 2022;12(1):13490. 10.1038/s41598-022-17543-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-17543-y</ArticleId><ArticleId IdType="pmc">PMC9355971</ArticleId><ArticleId IdType="pubmed">35931713</ArticleId></ArticleIdList></Reference><Reference><Citation>Nourbakhsh S, Fazil A, Li M, Mangat CS, Peterson SW, Daigle J, Langner S, Shurgold J, D’Aoust P, Delatolla R, Mercier E, Pang X, Lee BE, Stuart R, Wijayasri S, Champredon D. A wastewater-based epidemic model for SARS-CoV-2 with application to three Canadian cities. Epidemics 2022;39:100560. 10.1016/j.epidem.2022.100560</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.epidem.2022.100560</ArticleId><ArticleId IdType="pmc">PMC8993419</ArticleId><ArticleId IdType="pubmed">35462206</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellewell J, Abbott S, Gimma A, Bosse NI, Jarvis CI, Russell TW, Munday JD, Kucharski AJ, Edmunds WJ, Funk S, Eggo RM; Centre for the Mathematical Modelling of Infectious Diseases COVID-19 Working Group . Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts. Lancet Glob Health 2020;8(4):e488–96. 10.1016/S2214-109X(20)30074-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(20)30074-7</ArticleId><ArticleId IdType="pmc">PMC7097845</ArticleId><ArticleId IdType="pubmed">32119825</ArticleId></ArticleIdList></Reference><Reference><Citation>Levesque J, Maybury DW, Shaw RH. A model of COVID-19 propagation based on a gamma subordinated negative binomial branching process. J Theor Biol 2021. Mar;512:110536. 10.1016/j.jtbi.2020.110536</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtbi.2020.110536</ArticleId><ArticleId IdType="pmc">PMC7654309</ArticleId><ArticleId IdType="pubmed">33186594</ArticleId></ArticleIdList></Reference><Reference><Citation>Biron K, Drouin PL, Serre L. A branching process and simulation model to evaluate the spread of severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) in various environments: Enabling simultaneous mitigation strategies including social distancing masks symptomatic self isolation testing contact tracing and vaccination. Defence Research and Development Canada. Ottawa, ON: DRDC; 2023. https://pubs.drdc-rddc.gc.ca/BASIS/pcandid/www/engpub/DDW?W%3DSYSNUM=816419&amp;r=0</Citation></Reference><Reference><Citation>Volz E, Mishra S, Chand M, Barrett JC, Johnson R, Geidelberg L, Hinsley WR, Laydon DJ, Dabrera G, O’Toole Á, Amato R, Ragonnet-Cronin M, Harrison I, Jackson B, Ariani CV, Boyd O, Loman NJ, McCrone JT, Gonçalves S, Jorgensen D, Myers R, Hill V, Jackson DK, Gaythorpe K, Groves N, Sillitoe J, Kwiatkowski DP, Flaxman S, Ratmann O, Bhatt S, Hopkins S, Gandy A, Rambaut A, Ferguson NM; COVID-19 Genomics UK (COG-UK) consortium . Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England. Nature 2021;593(7858):266–9. 10.1038/s41586-021-03470-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03470-x</ArticleId><ArticleId IdType="pubmed">33767447</ArticleId></ArticleIdList></Reference><Reference><Citation>Medley GF. A consensus of evidence: the role of SPI-M-O in the UK COVID-19 response. Adv Biol Regul 2022;86:100918. 10.1016/j.jbior.2022.100918</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbior.2022.100918</ArticleId><ArticleId IdType="pmc">PMC9525209</ArticleId><ArticleId IdType="pubmed">36210298</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan P, Tan Y, Yang L, Aruffo E, Ogden NH, Bélair J, Heffernan J, Arino J, Watmough J, Carabin H, Zhu H. Assessing transmission risks and control strategy for monkeypox as an emerging zoonosis in a metropolitan area. J Med Virol 2023;95(1):e28137. 10.1002/jmv.28137</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28137</ArticleId><ArticleId IdType="pubmed">36089815</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrin T, Ayache D, Baumeister A, Young K, Pussegoda K, Ahmad R, Waddell L. COVID-19 literature surveillance-A framework to manage the literature and support evidence-based decision-making on a rapidly evolving public health topic. Can Commun Dis Rep 2023;49(1):5–9. 10.14745/ccdr.v49i01a02</Citation><ArticleIdList><ArticleId IdType="doi">10.14745/ccdr.v49i01a02</ArticleId><ArticleId IdType="pmc">PMC9902036</ArticleId><ArticleId IdType="pubmed">36815866</ArticleId></ArticleIdList></Reference><Reference><Citation>Colijn C, Earn DJ, Dushoff J, Ogden NH, Li M, Knox N, Van Domselaar G, Franklin K, Jolly G, Otto SP. The need for linked genomic surveillance of SARS-CoV-2. Can Commun Dis Rep 2022;48(4):131–9. 10.14745/ccdr.v48i04a03</Citation><ArticleIdList><ArticleId IdType="doi">10.14745/ccdr.v48i04a03</ArticleId><ArticleId IdType="pmc">PMC9017802</ArticleId><ArticleId IdType="pubmed">35480703</ArticleId></ArticleIdList></Reference><Reference><Citation>Public Health Agency of Canada. Update on COVID-19 in Canada: Epidemiology and Modelling. Ottawa, ON: PHAC; 2021. https://www.canada.ca/content/dam/phac-aspc/documents/services/diseases-maladies/coronavirus-disease-covid-19/epidemiological-economic-research-data/update-covid-19-canada-epidemiology-modelling-20210903-en.pdf</Citation></Reference><Reference><Citation>Ng V, Fazil A, Waddell LA, Turgeon P, Otten A, Ogden NH. Modelling the impact of shutdowns on resurging SARS-CoV-2 transmission in Canada. R Soc Open Sci 2021;8(5):210233. 10.1098/rsos.210233</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsos.210233</ArticleId><ArticleId IdType="pmc">PMC8190545</ArticleId><ArticleId IdType="pubmed">34123390</ArticleId></ArticleIdList></Reference><Reference><Citation>McCabe R, Kont MD, Schmit N, Whittaker C, Løchen A, Walker PG, Ghani AC, Ferguson NM, White PJ, Donnelly CA, Watson OJ. Communicating uncertainty in epidemic models. Epidemics 2021;37:100520. 10.1016/j.epidem.2021.100520</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.epidem.2021.100520</ArticleId><ArticleId IdType="pmc">PMC8562068</ArticleId><ArticleId IdType="pubmed">34749076</ArticleId></ArticleIdList></Reference><Reference><Citation>Betti MI, Abouleish AH, Spofford V, Peddigrew C, Diener A, Heffernan JM. COVID-19 Vaccination and Healthcare Demand. Bull Math Biol 2023;85(5):32. 10.1007/s11538-023-01130-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11538-023-01130-x</ArticleId><ArticleId IdType="pmc">PMC10021065</ArticleId><ArticleId IdType="pubmed">36930340</ArticleId></ArticleIdList></Reference><Reference><Citation>Public Health Agency of Canada. National Emergency Strategic Stockpile (NESS). Ottawa, ON: PHAC; 2024. [Accessed 2024 Sept 10]. https://www.canada.ca/en/public-health/services/emergency-preparedness-response/national-emergency-strategic-stockpile.html</Citation></Reference><Reference><Citation>Meurens F, Dunoyer C, Fourichon C, Gerdts V, Haddad N, Kortekaas J, Lewandowska M, Monchatre-Leroy E, Summerfield A, Wichgers Schreur PJ, van der Poel WH, Zhu J. Animal board invited review: risks of zoonotic disease emergence at the interface of wildlife and livestock systems. Animal 2021;15(6):100241. 10.1016/j.animal.2021.100241</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.animal.2021.100241</ArticleId><ArticleId IdType="pmc">PMC8172357</ArticleId><ArticleId IdType="pubmed">34091225</ArticleId></ArticleIdList></Reference><Reference><Citation>Mollentze N, Streicker DG. Predicting zoonotic potential of viruses: where are we? Curr Opin Virol 2023;61:101346. 10.1016/j.coviro.2023.101346</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2023.101346</ArticleId><ArticleId IdType="pubmed">37515983</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. WHO R&amp;D Blueprint for Epidemics Updating the WHO list of pathogens with epidemic and PHEIC potential. Geneva, CH: WHO; 2022. [Accessed 2024 Sept 10]. https://cdn.who.int/media/docs/default-source/blue-print/rd-blueprint_prioritization-2022_concept-note_v.1.pdf?sfvrsn=260e4e8f_3</Citation></Reference><Reference><Citation>Milwid RM, Li M, Fazil A, Maheu-Giroux M, Doyle CM, Xia Y, Cox J, Grace D, Dvorakova M, Walker SC, Mishra S, Ogden NH. Exploring the dynamics of the 2022 mpox outbreak in Canada. J Med Virol 2023;95(12):e29256. 10.1002/jmv.29256</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.29256</ArticleId><ArticleId IdType="pubmed">38054533</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis MA, Brown P, Colijn C, Cowen L, Cotton C, Day T, Deardon R, Earn D, Haskell D, Heffernan J, Leighton P, Murty K, Otto S, Rafferty E, Hughes Tuohy C, Wu J, Zhu H. Charting a future for emerging infectious disease modelling in Canada. 2023. https://dspace.library.uvic.ca/server/api/core/bitstreams/5bd170ff-aa27-4fdf-af36-6e341c3749d8/content</Citation></Reference><Reference><Citation>Jit M, Cook AR. Informing Public Health Policies with Models for Disease Burden, Impact Evaluation, and Economic Evaluation. Annu Rev Public Health 2024;45(1):133–50. 10.1146/annurev-publhealth-060222-025149</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-publhealth-060222-025149</ArticleId><ArticleId IdType="pubmed">37871140</ArticleId></ArticleIdList></Reference><Reference><Citation>Tariq M, Haworth-Brockman M, Moghadas SM. Ten years of Pan-InfORM: modelling research for public health in Canada. AIMS Public Health 2021;8(2):265–74. 10.3934/publichealth.2021020</Citation><ArticleIdList><ArticleId IdType="doi">10.3934/publichealth.2021020</ArticleId><ArticleId IdType="pmc">PMC8116193</ArticleId><ArticleId IdType="pubmed">34017890</ArticleId></ArticleIdList></Reference><Reference><Citation>Gojovic MZ, Sander B, Fisman D, Krahn MD, Bauch CT. Modelling mitigation strategies for pandemic (H1N1) 2009. CMAJ 2009;181(10):673–80. 10.1503/cmaj.091641</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.091641</ArticleId><ArticleId IdType="pmc">PMC2774362</ArticleId><ArticleId IdType="pubmed">19825923</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatia D, Allin S, Di Ruggiero E. Mobilization of science advice by the Canadian federal government to support the COVID-19 pandemic response. Humanit Soc Sci Commun 2023;10(1):19. 10.1057/s41599-023-01501-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1057/s41599-023-01501-8</ArticleId><ArticleId IdType="pmc">PMC9844194</ArticleId><ArticleId IdType="pubmed">36687774</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan S, Wang L, Birnkrant MJ, Zhai Z, Miller SL. Multizone modeling of airborne SARS-CoV-2 quanta transmission and infection mitigation strategies in office hotel retail and school buildings. Buildings 2023;13(1):102. 10.3390/buildings13010102</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/buildings13010102</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Airborne Risk Indoor Assessment. Geneva, CH: WHO; 2024. [Accessed 2024 Sept 10]. https://partnersplatform.who.int/aria</Citation></Reference><Reference><Citation>Champredon D, Fazil A, Ogden NH. Simple mathematical modelling approaches to assessing the transmission risk of SARS-CoV-2 at gatherings. Can Commun Dis Rep 2021;47(4):184–94. 10.14745/ccdr.v47i04a02</Citation><ArticleIdList><ArticleId IdType="doi">10.14745/ccdr.v47i04a02</ArticleId><ArticleId IdType="pmc">PMC8127697</ArticleId><ArticleId IdType="pubmed">34035664</ArticleId></ArticleIdList></Reference><Reference><Citation>Rees EE, Rodin R, Ogden NH. Population surveillance approach to detect and respond to new clusters of COVID-19. Can Commun Dis Rep 2021;47(56):243–50. 10.14745/ccdr.v47i56a01</Citation><ArticleIdList><ArticleId IdType="doi">10.14745/ccdr.v47i56a01</ArticleId><ArticleId IdType="pmc">PMC8219061</ArticleId><ArticleId IdType="pubmed">34220348</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludwig A, Berthiaume P, Orpana H, Nadeau C, Diasparra M, Barnes J, Hennessy D, Otten A, Ogden N. Assessing the impact of varying levels of case detection and contact tracing on COVID-19 transmission in Canada during lifting of restrictive closures using a dynamic compartmental model. Can Commun Dis Rep 2020;46(1112):409–21. 10.14745/ccdr.v46i1112a08</Citation><ArticleIdList><ArticleId IdType="doi">10.14745/ccdr.v46i1112a08</ArticleId><ArticleId IdType="pmc">PMC7799879</ArticleId><ArticleId IdType="pubmed">33447163</ArticleId></ArticleIdList></Reference><Reference><Citation>Martignoni MM, Arino J, Hurford A. Is SARS-CoV-2 elimination or mitigation best? Regional and disease characteristics determine the recommended strategy. R Soc Open Sci 2024;11(6):240186. 10.1098/rsos.240186</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsos.240186</ArticleId><ArticleId IdType="pmc">PMC11295893</ArticleId><ArticleId IdType="pubmed">39100176</ArticleId></ArticleIdList></Reference><Reference><Citation>Tupper P, Otto SP, Colijn C. Fundamental limitations of contact tracing for COVID-19. Facets 2021;6:1993–2001. 10.1139/facets-2021-0016</Citation><ArticleIdList><ArticleId IdType="doi">10.1139/facets-2021-0016</ArticleId></ArticleIdList></Reference><Reference><Citation>Soucy JR, Ghasemi A, Sturrock SL, Berry I, Buchan SA, MacFadden DR, Brown KA. Trends in Interregional Travel to Shopping Malls and Restaurants Before and After Differential COVID-19 Restrictions in the Greater Toronto Area. JAMA Netw Open 2021;4(8):e2123139. 10.1001/jamanetworkopen.2021.23139</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.23139</ArticleId><ArticleId IdType="pmc">PMC8408668</ArticleId><ArticleId IdType="pubmed">34463749</ArticleId></ArticleIdList></Reference><Reference><Citation>Hongoh V, Maybury D, Levesque J, Fazil A, Otten A, Turgeon P, Waddell L, Ogden NH. Decision analysis support for evaluating transmission risk of COVID-19 in places where people gather. Can Commun Dis Rep 2021;47(11):446–60. 10.14745/ccdr.v47i11a02</Citation><ArticleIdList><ArticleId IdType="doi">10.14745/ccdr.v47i11a02</ArticleId><ArticleId IdType="pmc">PMC8601102</ArticleId><ArticleId IdType="pubmed">34880707</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman B, Gaas B, McPhee-Knowles S, Guillouzic S, Kanary L. Development of an age-adjusted activity-based contact probability model for infectious diseases. Facets 2024;9:1–11. 10.1139/facets-2023-0094</Citation><ArticleIdList><ArticleId IdType="doi">10.1139/facets-2023-0094</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfson M. COVID-19 data and modeling: we need to learn from and act on our experiences. Can J Public Health 2024;115(4):535–40. 10.17269/s41997-024-00917-2</Citation><ArticleIdList><ArticleId IdType="doi">10.17269/s41997-024-00917-2</ArticleId><ArticleId IdType="pmc">PMC11382642</ArticleId><ArticleId IdType="pubmed">39060712</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia Y, Flores Anato JL, Colijn C, Janjua N, Irvine M, Williamson T, Varughese MB, Li M, Osgood N, Earn DJ, Sander B, Cipriano LE, Murty K, Xiu F, Godin A, Buckeridge D, Hurford A, Mishra S, Maheu-Giroux M. Canada’s provincial COVID-19 pandemic modelling efforts: A review of mathematical models and their impacts on the responses. Can J Public Health 2024;115(4):541–57. 10.17269/s41997-024-00910-9</Citation><ArticleIdList><ArticleId IdType="doi">10.17269/s41997-024-00910-9</ArticleId><ArticleId IdType="pmc">PMC11382646</ArticleId><ArticleId IdType="pubmed">39060710</ArticleId></ArticleIdList></Reference><Reference><Citation>Public Health Agency of Canada. Working with partners to modernize public health data. Ottawa, ON: PHAC; 2024. [Accessed 2024 Sept 10]. https://www.canada.ca/en/public-health/programs/pan-canadian-health-data-strategy.html</Citation></Reference><Reference><Citation>Canada Health Infoway. Shared Pan-Canadian Interoperability Roadmap. 2023. [Accessed 2024 Sept 10]. https://www.infoway-inforoute.ca/en/component/edocman/6444-connecting-you-to-modern-health-care-shared-pan-canadian-interoperability-roadmap/view-document?Itemid=101</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>